CareTrust REIT, Inc.
NYSE:CTREREIT - Healthcare Facilities
-$0.65 today
- Market cap
- $9.78B
- Beta
- 0.79
- P/E (TTM)
- 24.2
- EPS (TTM)
- $1.50
- Dividend yield
- 3.83%
Volume 3.66M
Average 3.30M
CTRE EBITDA Margin
EBITDA as a percentage of revenue.
CareTrust REIT, Inc.NYSE: CTRE
EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026
EBITDA Margin narrows to 77.2%
EBITDA Margin was 77.2% in Q3 FY2026, down 29.9 pp from a year earlier. On a trailing-twelve-month basis it was 89.0%, down 27.1 pp year over year. Over 3 fiscal years it widened by 58.1 pp.
Context
- EBITDA Margin widened in 3 of the last 3 fiscal years.
- FY2025 was the highest level in the 4 fiscal years shown.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 97.2% for the fiscal year ending Dec 2026, up from 96.9% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- 77.2%-7.5 pp QoQ
- Last fiscal yearDec 2025
- 96.9%+4.2 pp YoY
- LTMSep 2026
- 89.0%-27.1 pp YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -29.9 pp | +4.7 pp | +34.5 pp |
| 1 year | +4.2 pp | +0.2 pp | -4.0 pp |
| 3 years | +58.1 pp | -33.0 pp | -91.1 pp |
| 5 years | — | — | |
| 10 years | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 96.9%
- Year-over-year change
- +4.2pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 96.9% | +4.2pp |
| FY2024 | 2024-12-31 | 92.7% | +19.3pp |
| FY2023 | 2023-12-31 | 73.4% | +34.6pp |
| FY2022 | 2022-12-31 | 38.9% | -40.6pp |
| FY2021 | 2021-12-31 | 79.4% | — |
EBITDA Margin vs competitors
How CTRE compares with its peers on the latest reported figures
- CTRE's LTM Sep 2026 EBITDA Margin of 89.0% is the 4th highest of the 11 companies compared; the peer median is 62.0%.
- Its year-over-year change of -27.1 pp is the lowest of 10, against a peer median of +20.3 pp.
- Over three fiscal years its change of +58.1 pp compares with a peer median of +4.6 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Sep 2026 | 186.2% | +107.9 pp | +10.3 pp | |
| LTM Jun 2026 | 112.1% | +20.3 pp | -16.4 pp | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | 103.2% | +116.1 pp | -52.3 pp |
| LTM Sep 2026 | 89.0% | -27.1 pp | +58.1 pp | |
| LTM Mar 2026 | 84.4% | +2.7 pp | +12.4 pp | |
| LTM Sep 2026 | 78.5% | +24.2 pp | -16.5 pp | |
| LTM Jun 2026 | 45.5% | -19.4 pp | +24.3 pp | |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | 24.6% | — | +7.8 pp |
| LTM Sep 2026 | 24.3% | -11.8 pp | -13.6 pp | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | 21.5% | +26.8 pp | +8.0 pp |
| LTM Sep 2026 | 18.1% | +3.4 pp | +1.5 pp | |
| Peer median (excluding CTRE) | 62.0% | +20.3 pp | +4.6 pp | |
Competitors are the stored peer set for CTRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 190.2M | 187.51M | 198.6M | 228.26M | 476.59M |
| Cost of Revenue | 3.57M | 9.37M | 9.59M | 13.55M | 194.8M |
| Gross Profit | 186.62M | 178.13M | 189.01M | 214.71M | 281.79M |
| Gross Margin | 98.1% | 95.0% | 95.2% | 94.1% | 59.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 26.87M | 19.27M | 20.9M | 27.9M | 138K |
| Operating Expenses | 82.21M | 74.33M | 73M | 90.65M | (38.35M) |
| Depreciation & Amortization | 55.39M | 50.38M | 51.26M | 56.93M | 93.05M |
| EBITDA | 151.05M | 72.88M | 145.86M | 211.64M | 462.04M |
| EBITDA Margin | 79.4% | 38.9% | 73.4% | 92.7% | 96.9% |
| Operating Income | 104.41M | 103.81M | 116M | 124.06M | 320.14M |
| Operating Margin | 54.9% | 55.4% | 58.4% | 54.3% | 67.2% |
| Interest Income | 2.16M | 8.63M | 19.17M | 68.03M | 11.49M |
| Interest Expense | 23.68M | 30.01M | 40.88M | 30.31M | 43.71M |
| Other Income / Expenses | (32.43M) | (111.32M) | (62.28M) | 344K | 5.15M |
| Income Before Tax | 71.98M | (7.51M) | 53.72M | 124.4M | 325.29M |
| Pre-Tax Margin | 37.8% | -4.0% | 27.1% | 54.5% | 68.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 5M |
| Net Income | 71.98M | (7.51M) | 53.74M | 125.08M | 320.54M |
| Net Margin | 37.8% | -4.0% | 27.1% | 54.8% | 67.3% |
| EPS (Basic) | 0.50 | (0.08) | 0.50 | 0.81 | 1.57 |
| EPS (Diluted) | 0.50 | (0.08) | 0.50 | 0.80 | 1.57 |
| Weighted Avg Shares | 96.02M | 96.7M | 105.96M | 154.8M | 203.64M |
| Weighted Avg Shares (Diluted) | 96.09M | 96.7M | 106.15M | 155.17M | 204.09M |
CareTrust REIT, Inc.
NYSE:CTRE
Intrinsic Alpha fair value
Locked
Current Price
$37.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.